As of 2024-12-12, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (34.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -77925.5%.
The range of the Relative Valuation is (35.47) - (39.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 44.9x | 34.7x |
| Forward P/E multiples | 19.8x - 31.3x | 20.5x |
| Fair Price | (35.47) - (39.40) | (34.79) |
| Upside | -79448.2% - -88245.8% | -77925.5% |
| Date | P/E |